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/ -------- breakdown, 9 is rate of removal via protein synthesis and 8 is rate of removal via amino acid involved in the final calculations of protein turnover from amino acid flux (such as the labelling of precursor pools within tissues and a knowledge of the composition of protein in the tissues with respect to leucine) we have attempted to validate them.
So far as instrumentation is concerned, the isotoperatio mass spectrometer is capable of detecting one part per 106 with a precision of o.I%, and gas-liquid chromatography plus mass spectrometry of detecting five parts in 103 with a precision of 2.07'. These are adequate since the errors do not approach those introduced by biological variation and sample handling before the final measurement. Furthermore, the latter errors are sufficiently small to allow the detection of physiologically-and pathologically-meaningful alterations in protein turnover (see Table I ).
VOl. 43
Model systems in nutritional research ' 9 ' So far as precursor labelling is concerned we are limited in the extent to which we can approach this problem by the size of tissue samples obtainable. Nevertheless, we have been able to measure enrichment of leucine in the intracellular pool in a variety of muscles, including heart muscle, and also in skin and bowel serosa ( Table 2 ) . One useful finding has been that the enrichment of leucine in the free pool in muscle and in plasma is close, in both the fed and fasted conditions, to the enrichment of the transamination product of leucine (a-ketoisocaproate). We have therefore felt justified in making calculations of synthesis rate and whole-body protein turnover on the basis of a-ketoisocaproate labelling.
The concentration of leucine in the tissues compared with that of the whole body is of importance in calculating the scaling factor between leucine turnover and whole-body protein turnover. Although for many years values of 8% leucine in whole-body protein and 100/c in muscle protein have been used, these values were based on interpolation rather than on an analysis of whole human carcass (for discussion, see Reeds & Harris, 1981). Reeds & Harris (198r) , by analysis of whole sheep and steer carcasses, found 6.6% leucine in protein. We have recently analysed leucine in samples of all the major human tissues taken during autopsy of individuals who suffered sudden accidental death. It is difficult to believe from these results ( Table 3 ) that the currently-accepted valuesof leucine as 8% of the whole-body protein should be revised downwards by one-quarter unless our understanding of the size of the tissue compartments in man is incorrect.
Whatever our methodological problems, we feel sure that we can produce biologically-meaningful information. Among a number of pieces of evidence that this is so is the finding that in man, as in animals, a linear relationship exists between protein synthetic rate and muscle RNA concentration in samples taken from limb, trunk and heart muscle in patients during operation (Fig. 2) . 
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Furthermore, in response to a given stimulus, we see changes in whole-body turnover and in muscle protein synthesis in man which are consonant with the changes observed in animals. Although results of other studies concerning the relative proportions in man of protein turnover in muscle and in the whole body ( I :2) or the absolute value of protein synthesis in these compartments are not in agreement with our results, there seems little doubt that the twofold changes we found in protein synthetic activity of muscle and the whole body in response to feeding and fasting (Rennie et al. 1982b ) are real biological phenomena. Furthermore, we have been able to observe large differences between normal subjects and those suffering from a number of pathological conditions which cause wasting of skeletal muscle: the differences are so great that it is difficult to believe that they arise from methodological problems (Rennie et al. 1983 ). Generally we observe that in muscle wasting there is a depression in the rate of muscle protein synthesis. We do not see a rapid change in the muscle mass and conclude that, at least in the chronic stages of many myopathies and in wasting due to cancer and surgical operation, the loss of tissue protein is due to a fall in the replacement of protein by synthetic processes.
This view is for the moment largely hypothetical since we do not have good methods for the measurement of protein breakdown. We have attempted to develop such methods in two ways. One approach has been to measure the efflux of 3-methylhistidine, an amino acid which is released from myofibrillar proteins on degradation and not re-utilized : this is achieved by measuring the concentration of the amino acid in arterial blood and venous blood draining the muscles of the leg (Lundholm et al. 1982) . We have been able to show that, contrary to general expectations, the increased total a-amino-nitrogen efflux associated with muscle wasting is not found in certain chronic conditions such as cancer cachexia and malnutrition. Furthermore, following mild to moderate trauma accompanying elective gastrointestinal surgery, there is no indication of an increase in 3-methylhistidine efflux from leg tissues at the time when total N excretion is markedly increased (Rennie et al. 1984) . At present these techniques simply measure the amounts of 3-methylhistidine1 and of tyrosine, as indicators of total a-NH,-N balance. The usefulness of the technique is to some extent limited by the difficulty of measuring very small concentrations of ymethylhistidine. The measurement of 3-methylhistidine may be made more sensitive and precise by the use of mass-spectrometric techniques (Matthews et al. I 98 I a,b) and even more information may be obtained in the future by measuring the dilution between arterial and venous blood of exogenously-labelled 3-methylhistidine.
Another approach is to gain some insight into the processes of muscle synthesis and degradation by means of monitoring the uptake and release of leucine in muscle tissues (or indeed any other tissues accessible to arterial and venous blood measurements) and leucine oxidation. We have applied these techniques in studies of normal subjects and in those with wasting diseases of muscle. For example, by measuring the dilution of label between arterial and venous circulations in leucine and its keto acid a-ketoisocaproate and by measuring the production of labelled VOl. 43 (Fig. 3) . It may be that for the purposes of probing intracellular metabolism, leucine is not the best tracer to use for muscle because of transaminating reactions; phenylalanine and tyrosine, which are not metabolized in muscle, may give clearer results. Nevertheless, whatever the tracer to be used, gas chromatography-mass spectrometry appears to be the method of choice since the precision of estimation of fractional labelling is so much better than with alternative methods based on radiochemical techniques.
Model systems in nutritional research
In summary, the use of stable isotope-labelled tracers in metabolism has increased greatly in recent times (Halliday & Rennie, 1982; Matthews & Bier, 1983) due to the ease of application of techniques which are effectively hazard-free and potentially much more powerful and precise than previous techniques. We have concentrated here on measurements using amino acids as tracers but of
196
SYMPOSIUM PROCEEDINGS
I984
course the same techniques could be used with fat and carbohydrate tracers. It is our expectation that the application of such techniques in metabolic and nutritional research will considerably extend our knowledge in this area.
